Inmode Ltd (INMD) Stock Price, Quote & News

Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well a...

Industry: Medical Devices

Sector: Healthcare

Phone: 972 4 909 6313

Website: www.inmodemd.com

Address:

Tavor Building, Sha’ar Yokneam PO Box 533, Yokne'am, Israel

Gio465 Aug. 5 at 10:18 PM

$INMD Oh how far have we fallen¡

0 · Reply

findingthestock Aug. 5 at 7:15 PM

$INMD @LongJohnAg They are similar to how Inmode was when they started out and with Morpheus 8 Sofwave Medical Q2 2025 shows strong revenue growth Sofwave Medical Ltd reported robust financial results for the second quarter of fiscal year 2025, showcasing a 43% year-over-year revenue growth to $21 million. The company achieved its first net income of $1.5 million, driven by significant recurring revenue and efficient cost management. Its stock price surged 17.05%, closing at $2,870, reflecting investor confidence in the company’s performance and growth prospects

1 · Reply

findingthestock Aug. 5 at 5:23 PM

$INMD Can ibmode buy softwave if not they will lose market cap

1 · Reply

_StockFox_ Aug. 5 at 3:31 AM

$INMD ppl forget fhat price and price action matters just as much as fundamentals...i dont know when this will turn up but watch for that sideways stabilization and think deep about volume you are seeing along with the contraction of volatility.. May take some time..but im here

0 · Reply

ManosDeDiamante07 Aug. 1 at 9:00 PM

$INMD This will be a great one if you’re patient

0 · Reply

findingthestock Jul. 31 at 10:36 PM

$INMD Stock is crashing if you listen to the earning calls all the analysts you could tell weren’t buying Moshe excuses I would expect DOMA to send another letter I want the stock to go up but MANAGEMENT IS HOLDING IT BACK I am hoping DOMA and large shareholders can get them out

0 · Reply

findingthestock Jul. 31 at 12:54 PM

$INMD We don’t have any acquisition on the pipeline. So I cannot announce that we’re doing any acquisition this year. As far as dividend, it might, but it also require dividend tax. So basically, everything is possible. We will need to see how the continue of the year will go, and probably we’ll make a decision sometime in the next 6 months. https://www.insidermonkey.com/blog/inmode-ltd-nasdaqinmd-q2-2025-earnings-call-transcript-1580458/ InMode Ltd. (NASDAQ:INMD) Q2 2025 Earnings Call Transcript - Insider Monkey

0 · Reply

AnalyticaInvestor Jul. 31 at 10:51 AM

$INMD $PRME $GP $DUOT $FVRR Fed holds rates steady, praise meets pushback. Powell says “keep politics out,” but Trump’s South Korea deal lifts secondary indices. Tariff risks rising on copper and low-value imports. 📊 Read the full Analytica Alpha to see how this impacted small caps Yesterday. https://analyticainvestor.beehiiv.com/p/fed-holds-dbeefbaca9d03f3e

0 · Reply

JarvisFlow Jul. 30 at 4:39 PM

Needham updates rating for InMode ( $INMD ) to Hold.

0 · Reply

tknofile Jul. 30 at 2:14 PM

$INMD devices are sold, yes, they earn $26.7m in net income. Yes, they spent $27.4m for buybacks. Seems like a HOLD.

1 · Reply

InMode to Participate in Upcoming Investor Conferences

Jul 30, 2025, 3:22 PM EDT - 6 days ago

InMode Ltd. (INMD) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 7:00 AM EDT - 6 days ago

InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins

Jul 12, 2025, 8:08 AM EDT - 24 days ago

InMode: Margin Pressure, But Optionality Makes It Worth A Look

Jul 10, 2025, 7:00 AM EDT - 26 days ago

InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M

May 28, 2025, 8:30 AM EDT - 2 months ago

InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

May 9, 2025, 8:22 AM EDT - 3 months ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program

May 7, 2025, 8:30 AM EDT - 3 months ago

InMode to Present at Upcoming Investor Conferences and Events

May 6, 2025, 8:03 AM EDT - 3 months ago

InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges

Apr 29, 2025, 7:00 AM EDT - 3 months ago

InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade)

Apr 29, 2025, 1:52 AM EDT - 3 months ago

InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade)

Apr 28, 2025, 1:41 PM EDT - 3 months ago

Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City

Apr 28, 2025, 11:53 AM EDT - 3 months ago

InMode Ltd. (INMD) Q1 2025 Earnings Call Transcript

Apr 28, 2025, 7:00 AM EDT - 3 months ago

InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease

Apr 3, 2025, 4:26 AM EDT - 4 months ago

InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade)

Mar 26, 2025, 8:30 AM EDT - 4 months ago

InMode to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 6, 2025, 7:30 AM EST - 5 months ago

InMode Responds to Doma Perpetual's Letters

Mar 3, 2025, 8:30 AM EST - 5 months ago

InMode to Present at Upcoming Investor Conferences

Feb 10, 2025, 1:14 AM EST - 6 months ago

InMode: Plastic Surgery Boom, Cash Flow, And Cheap

Feb 6, 2025, 9:08 AM EST - 6 months ago

InMode Ltd. (INMD) Q4 2024 Earnings Call Transcript

Feb 4, 2025, 7:00 AM EST - 6 months ago

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

Feb 3, 2025, 8:30 AM EST - 6 months ago

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

Jan 28, 2025, 9:32 AM EST - 6 months ago

InMode: A Clear Bargain With Unique Risks

Jan 16, 2025, 7:00 AM EST - 7 months ago

InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced

Jan 15, 2025, 8:05 AM EST - 7 months ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback

Jan 10, 2025, 6:07 AM EST - 7 months ago

InMode: Clearly, I Was Too Optimistic (Rating Downgrade)

Jan 8, 2025, 7:00 AM EST - 7 months ago

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M

Dec 12, 2024, 1:17 AM EST - 8 months ago

InMode: Product Origination And Undervaluation Make The Stock A Buy

Nov 5, 2024, 9:43 AM EST - 9 months ago

InMode: $25/Share Is Closer Than You Think

Oct 31, 2024, 12:16 PM EDT - 9 months ago

InMode: A Deep Dive After Q3 Earnings

Oct 30, 2024, 11:33 AM EDT - 9 months ago

InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 7:00 AM EDT - 9 months ago

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

Oct 24, 2024, 7:03 AM EDT - 10 months ago

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

Oct 10, 2024, 7:00 AM EDT - 10 months ago

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

Oct 4, 2024, 8:00 AM EDT - 10 months ago

Stock Picks From Seeking Alpha's September 2024 New Analysts

AME CCL CRWD CUK DVN EGO EMR

Oct 1, 2024, 7:00 AM EDT - 11 months ago

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy

Sep 19, 2024, 7:14 AM EDT - 11 months ago

InMode Offers High Risk-Reward Opportunity Amid New Products And Rate Cuts (Rating Upgrade)

Sep 10, 2024, 7:00 AM EDT - 11 months ago

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares

Sep 6, 2024, 4:38 AM EDT - 11 months ago

InMode Stock: An Inverse Bubble Caused By Short-Term Trouble

Sep 4, 2024, 8:30 AM EDT - 11 months ago

InMode to Present at 2024 Baird Global Healthcare Conference

Aug 1, 2024, 11:19 AM EDT - 1 year ago

InMode Ltd. (INMD) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 7:00 AM EDT - 1 year ago

InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M

Jul 31, 2024, 8:03 AM EDT - 1 year ago

InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform

Jul 25, 2024, 8:15 AM EDT - 1 year ago

DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer

Jul 17, 2024, 8:03 AM EDT - 1 year ago

Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling

Jul 11, 2024, 8:30 AM EDT - 1 year ago

InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024

Jun 13, 2024, 11:49 AM EDT - 1 year ago

InMode: Reversing Previous Shareholder Dilution With Buybacks

May 16, 2024, 8:00 AM EDT - 1 year ago

InMode to Present at Jefferies Healthcare Conference

May 8, 2024, 8:03 AM EDT - 1 year ago

InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand

May 2, 2024, 7:00 AM EDT - 1 year ago

InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M;

Gio465 Aug. 5 at 10:18 PM

$INMD Oh how far have we fallen¡

0 · Reply

findingthestock Aug. 5 at 7:15 PM

1 · Reply

findingthestock Aug. 5 at 5:23 PM

$INMD Can ibmode buy softwave if not they will lose market cap

1 · Reply

_StockFox_ Aug. 5 at 3:31 AM

0 · Reply

ManosDeDiamante07 Aug. 1 at 9:00 PM

$INMD This will be a great one if you’re patient

0 · Reply

findingthestock Jul. 31 at 10:36 PM

0 · Reply

findingthestock Jul. 31 at 12:54 PM

0 · Reply

AnalyticaInvestor Jul. 31 at 10:51 AM

0 · Reply

JarvisFlow Jul. 30 at 4:39 PM

Needham updates rating for InMode ( $INMD ) to Hold.

0 · Reply

tknofile Jul. 30 at 2:14 PM

$INMD devices are sold, yes, they earn $26.7m in net income. Yes, they spent $27.4m for buybacks. Seems like a HOLD.

1 · Reply

findingthestock Jul. 30 at 1:40 PM

$INMD It’s going down issue is Moshe using same excuses and their devices aren’t selling No one has confidence they can turn things around If it wasn’t for the cash on hand the stock price would easily below $10 It’s heading that way regardless Did Moshe announce buyback? Did Moshe announce any acquisitions? What are they doing with the cash?

0 · Reply

Z3mcoupe999 Jul. 30 at 1:36 PM

$INMD needs a management shakeup current CEO just is not upto the task in hand

0 · Reply

findingthestock Jul. 30 at 1:02 PM

$INMD SO PREDICTABLE Moshe with the same excuses Issue is in North America their devices aren’t selling ** Quarterly revenues from consumables and service of $19.8 million, a decrease of 6% compared to the second quarter of 2024. The second quarter reflects the broader trends we've seen in recent months, with persistent external headwinds, including ongoing macroeconomic uncertainty and a more cautious consumer behavior," said Moshe Mizrahy, Chief Executive Officer of InMode. "While these factors have impacted our results, we remain disciplined in our execution and committed to investing in the capabilities and growth drivers that will enable us to emerge stronger and deliver sustainable long-term value. Quarterly revenues from consumables and service of $19.8 million, a decrease of 6% compared to the second quarter of 2024.

1 · Reply

StardustTrader Jul. 30 at 12:50 PM

$INMD majorly priced in. Shouldnt see new lows. Good add from 13-15

0 · Reply

harrysown Jul. 30 at 12:28 PM

$INMD This is a shit earnings report. Surprised stock is higher pre market.

1 · Reply

DonCorleone77 Jul. 30 at 11:19 AM

$INMD InMode reports Q2 EPS 42c, consensus 41c -- Q2 revenue $95.60M, consensus $94.22M. -- Lowers FY25 non-GAAP EPS view to $1.55-$1.59 from $1.64-$1.68 -- Lowers FY25 revenue view to $365M-$375M from $395M-$405M. -- Consensus is for FY25 EPS $1.58 and for revenue $363M.

0 · Reply

romroc25 Jul. 29 at 12:16 PM

$INMD A sound Co but let's attack Jews, a smallish cult surrounded and hounded by the real infidels disguised by beards and burquas.

0 · Reply

Awiz2 Jul. 28 at 12:47 PM

$INMD Time this moves over $20.00

1 · Reply

findingthestock Jul. 27 at 11:28 PM

$INMD Stock market at highs and Moshe continues to use macrotrends as an excuse InMode has lowered its full-year 2025 revenue guidance to between $365 million and $375 million, down from a previous range of $395 million to $405 million due to factors including continued market weakness and uncertainty in the U.S. economic outlook.

0 · Reply

findingthestock Jul. 23 at 8:04 PM

$INMD I HOPE this has been the bottom and this crap stock can go up now There isn’t any catalysts All the news and guidance has been gloomy Much the same as 2024 is 2025 Can this get back to 15 Then 16 And I’m thinking best case this ends 2025 in 17!?! Maybe

1 · Reply

BlockheadCapital Jul. 18 at 7:02 PM

$INMD 😂

0 · Reply

Market Cap	889.35M
Revenue (ttm)	394.82M
Net Income (ttm)	181.28M
EPS (ttm)	N/A
PE Ratio	8.04
Forward PE	9.88
Profit Margin	45.91%
Debt to Equity Ratio	0.00

Volume	1,641,200
Avg Vol	1,398,060
Day's Range	N/A - N/A
Shares Out	63.21M
Stochastic %K	48%
Beta	1.93
Analysts	Sell
Price Target	$16.45